Covid-19 roundup: Eli Lilly declares success on JAK blocker in NIH trial; UK gives small biotech a big vaccine deal
The NIH-led study that gave the world the first positive, randomized remdesivir result has come back with a second one, showing that, when combined with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
